Editorial Comment
Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs
1Department of Physiology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology; Research Unit, Rambam Health Care Campus; Haifa-Israel
2Department of Nephrology, EMMS Nazareth-The Nazareth Hospital, Nazareth, Galilee Medical School-Bar Ilan University; Safed-Israel
2Department of Nephrology, EMMS Nazareth-The Nazareth Hospital, Nazareth, Galilee Medical School-Bar Ilan University; Safed-Israel
Anatol J Cardiol 2015; 15(4): 311-312 PubMed ID: 25880290 PMCID: 5336840 DOI: 10.5152/akd.2015.15072